Three Stocks That Might Be Undervalued In September 2024 [Yahoo! Finance]
Alnylam Pharmaceuticals, Inc. (ALNY)
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.alnylam.com/investor-overview
Company Research
Source: Yahoo! Finance
Top 10 Undervalued Stocks Based On Cash Flows Name Current Price Fair Value (Est) Discount (Est) Zhongji Innolight (SZSE:300308) CN¥115.94 CN¥231.41 Ningxia Baofeng Energy Group (SHSE:600989) CN¥14.45 CN¥28.76 Kotobuki Spirits (TSE:2222) ¥1719.00 ¥3434.73 Plus Alpha ConsultingLtd (TSE:4071) ¥2087.00 ¥4159.01 Napatech (OB:NAPA) NOK32.00 NOK63.99 Informa (LSE:INF) £8.458 £16.88 Shanghai INT Medical Instruments (SEHK:1501) HK$28.20 HK$56.09 EVERTEC (NYSE:EVTC) US$33.14 US$65.97 Hiconics Eco-energy Technology (SZSE:300048) CN¥4.36 CN¥8.70 Vertex Pharmaceuticals (NasdaqGS:VRTX) US$478.65 US$956.80 We'll examine a selection from our screener results. Overview: Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference, with a market cap of $33.62 billion. Operations: The company generates $2.34 billio
Show less
Read more
Impact Snapshot
Event Time:
ALNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALNY alerts
High impacting Alnylam Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ALNY
News
- Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $300.00 price target on the stock.MarketBeat
- RNA-Based Therapeutics Market to Grow by USD 1.27 Billion (2024-2028) Due to Increased Investment and Funding, AI Trends Impacting Revenue - Technavio [Yahoo! Finance]Yahoo! Finance
- Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $220.00 price target on the stock.MarketBeat
- Alnylam Pharmaceuticals, Inc. (ALNY): Do Hedge Funds Recommend This Biotech Stock Now? [Yahoo! Finance]Yahoo! Finance
- Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $300.00 price target on the stock.MarketBeat
ALNY
Earnings
- 8/1/24 - Beat
ALNY
Sec Filings
- 8/22/24 - Form 4
- 8/20/24 - Form 144
- 8/14/24 - Form 4
- ALNY's page on the SEC website